ETHIOPATHOGENETIC BIOMARKERS FOR THE FORMATION OF HEPATOSPLENOMEGAL SYNDROME AND THE CHOICE OF TREATMENT OF PATIENTS WITH ESOPHAGEAL PHLEBECTASIS BLEEDING

  • O. M. Klimova
  • S. V. Sushkov
  • T. I. Kordon
  • L. A. Drozdova
  • R. M. Smachilo
  • V. A. Lazirsky
  • K. O. Bychenko
Keywords: syndrome of hepatosplenomegaly, phagocytes, biomarkers, phlebectasia of the esophagus.

Abstract

Summary. A range of specific biomarkers to evaluate the severity of the condition, the choice of tactics, effectiveness and prognosis of treatment are used.

Goal. Evaluation of biomarkers characterizing the etiopathogenetic disorders in hepatosplenomegaly syndrome complicated by recurrent bleeding from esophageal phlebectasis to select individual treatment tactics.

Materials and methods. The digestive function of phagocytes is investigated, the concentration of opsonizing, membranotropic cytotoxic factors and the degree of endogenous intoxication in 3 groups of patients with different etiological factors of hepatosplenomegaly, complicated by bleeding are evaluated.

Results. The presence of specific trigger factors (viral hepatitis, herpes viruses, hereditary-related disorders of lysosomal enzymes) made it possible to classify patients into three groups. In the first group of patients with viral hepatitis B and C the induction of phagocytic activity of neutrophils, a significant increase in lymphocytotoxicity on the background of disorders of protein and lipid metabolism showed. In the second group of patients with the presence of herpes group viruses and autoimmune component an imbalance of opsonizing factors revealed, in particular proteins of the complement system, which caused impaired clearance of low molecular weight immune complexes and products of their degradation. In the third group of patients with hepatitis a significant decrease in the activity of lysosomal enzymes of phagocytic cells are found. The identified pathogenetic biomarkers indicate the presence in this group of patients with congenital enzymopathy characteristic of accumulation diseases. For patients with a pronounced manifestation of intercellular interactions disorders, as an effective alternative to liver transplantation the use of transfusions of mesenchymal stem cells, which are capable of trans differentiation under the influence of mediator microenvironment factors may be.

References

1. Бова А.А., Криушев П.В. К вопросу о дифференциальной диагностике гепатоспленомегалии. // Военная медицина. – 2013. – №: 4. – С. 18-25.
2. Бойко В.В., Авдосьев Ю.В., Грома В.Г., Лыхман В.Н., Шевченко А.Н., Мирошниченко Д.А. Лечение больных внутрипеченочной портальной гипертензией осложненной кровотечением из флебэктазий пищевода и желудка с применением миниинвазивных методов // Медицина. – 2015. – Т.14. – №2. – С.33-38.
3. Затевахин И.И., Цициашвили М.Ш., Шиповский В.Н., Монахов Д.В., Пан А.В. Печеночная энцефалопатия у больных циррозом печени до и после TIPS // Анналы хирургической гепатологии. – 2015. – Т.20. – №2. – С.40-45.
4. Клімова О. М., Кордон Т. І., Смачило Р. М., Белозьоров І. В., Биченко К. О., Мережко О. С., Кудревич О. М. Диференціальна діагностика і корекція метаболічних та імунологiчних порушень у хворих з цирозом печінки, ускладненим гепатоспленомегалією та портальною гіпертензією // Актуальні проблеми сучасної медицини. – 2019 . – Вип. 4. – С.30-41.
5. Пасиешвили Л.М., Бобро Л.Н. Синдром спленомегалии в практике семейного врача // Український терапевтичний журнал. – 2007.– №2.– С.112-122.
6. Савченко В. Г., Мамотюк К. С. Спленомегалия: руководство по внутренним болезням для врачей общей практики / под ред. Ф. И. Комарова. // М.: МИА. – 2007. – С. 793–802.
7. Скуратов А.Г., Петренев Д.Р., Кондрачук А.Н. Гепатоцитарная дифференцировка мехенхимальных стволовых клеток // Проблемы здоровья и экологии. – 2013. – №1. – С.29-35.
8. Gabrielian N.I., Savostyanova O.A. Indicative test for the diagnosis of septic processes // Laboratornoe delo,. – 1997. №2. – С. 79-80.
9. Knutson M., Wessling-Resnick M. Iron metabolism in the reticuloendothelial system // Crit Rev Biochem Mol Biol. – 2003. – V. 38(1). – Р. 61–88.
10. Kuramitsu K., Sverdlov D.Y., Liu S.B. et al. Failure of fibrotic liver regeneration in mice is linked to a severe fibrogenic response driven by hepatic progenitor cell activation // Am J Pathol. – 2013. – V. 183(1). –Р.182–194.
11. Wynn T.A., Vannella K.M. Macrophages in tissue repair, regeneration, and fibrosis // Immunity. – 2016. – V 44(3). – Р. 450–462.
Published
2020-04-20
How to Cite
Klimova, O. M., Sushkov, S. V., Kordon, T. I., Drozdova, L. A., Smachilo, R. M., Lazirsky, V. A., & Bychenko, K. O. (2020). ETHIOPATHOGENETIC BIOMARKERS FOR THE FORMATION OF HEPATOSPLENOMEGAL SYNDROME AND THE CHOICE OF TREATMENT OF PATIENTS WITH ESOPHAGEAL PHLEBECTASIS BLEEDING. Kharkiv Surgical School, (2), 193-200. https://doi.org/10.37699/2308-7005.2.2020.37
Section
ORIGINAL RESEARCHES

Most read articles by the same author(s)